Use of the levonorgestrel-releasing intrauterine system in breast cancer patients Xuan Bich Trinh, M.D., Wiebren A.A. Tjalma, M.D., Ph.D., Amin P. Makar, M.D., Ph.D., Guy Buytaert, M.D., Joost Weyler, M.D., Ph.D., Peter A. van Dam, M.D., Ph.D. Fertility and Sterility Volume 90, Issue 1, Pages 17-22 (July 2008) DOI: 10.1016/j.fertnstert.2007.05.033 Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions
Figure 1 Kaplan-Meier survival curve: LNG IUS breast cancer patients vs. control cohort. Fertility and Sterility 2008 90, 17-22DOI: (10.1016/j.fertnstert.2007.05.033) Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions
Figure 2 Kaplan-Meier survival curve: LNG IUS breast cancer patients who had a LNG IUS at time of diagnosis and continued using it (subgroup A) vs. control cohort. Fertility and Sterility 2008 90, 17-22DOI: (10.1016/j.fertnstert.2007.05.033) Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions